DLin-MC3-DMA CAS NO.1224606-06-7

The cationic lipid material DLin-MC3-DMA supplied by AVT, as a new type of cationic lipid, is the representative of ionizable cationic lipid and has the advantage of "low toxicity and high efficiency". Its chemical name is 4-( N,N-dimethylamino)butyric acid (6Z,9Z,28Z,31Z)-heptane-30,6,9,28,31-tetral-19-base lipid, with the world's first siRNA liposome product Onpattro launched in the US ，DLin-MC3-DMA attracts much attention.

cationic liposome DLin-MC3-DMA丨1224606-06-7-AVT (Shanghai) Pharmaceutical Tech Co,. Ltd.

1 English name:DLin-MC3-DMA
2 Product name:DLin-MC3-DMA
3 Chemical Name:(6Z,9Z,28Z,31Z)-heptatriacont-6,9,28,31-tetraene-19-yl 4-(dimethylamino)butanoate
4 Molecular formula:C₄₃H₇₉NO₂
5 manufacturer:AVT (Shanghai) Pharmaceutical Tech Co,. Ltd.
6 CAS NO. 1224606-06-7
7 level:Reagent grade
8 Executive Standard:Corporation standard
9 use:Cationic liposome
10 Chemical Structure
11 Character:Colorless to light yellow oily liquid
12 purity:98%
13 Solubility:Insoluble in water; soluble in DMSO (43.3 mg/ mL) and methanol, ethanol (16.7 mg/mL).
14 Molecular weight:642.09
15 stability:12 months
16 QC:corporation standard
17 Storage Conditions:-20℃
18 Precautions:Avoid contact with strong acids, strong bases and strong oxidizing substances